Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $0.30 |
Close | $0.31 |
Volume / Avg. | 638.66K / 3.96M |
Day Range | 0.30 - 0.31 |
52 Wk Range | 0.25 - 6.79 |
Market Cap | $18.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 7.75% |
Days to Cover | 2.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
There is no analysis for Lyra Therapeutics.
Lyra Therapeutics has a consensus price target of $8.38.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.307 last updated July 26, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.